These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6814594)

  • 21. [2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
    Garcia-Giralt E; Omodei Zorini C; Ferri L; Ayme Y; Carton M; Daban A; Delozier T; Fargeot P; Fumoleau P; Gorins A
    Clin Ter; 1994 Aug; 145(8):113-21. PubMed ID: 7955956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminoglutethimide after tamoxifen therapy in advanced breast cancer: M. D. Anderson Hospital experience.
    Buzdar AU; Powell KC; Blumenschein GR
    Cancer Res; 1982 Aug; 42(8 Suppl):3448s-3450s. PubMed ID: 7083209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changing role of endocrine therapy in the management of advanced breast cancer.
    Hayward JL
    Eur J Cancer (1965); 1980; Suppl 1():81-2. PubMed ID: 6274641
    [No Abstract]   [Full Text] [Related]  

  • 24. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast?
    Sterns EE; Bird CE; Mackie KW
    Can J Surg; 1982 Nov; 25(6):695-7. PubMed ID: 7139430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reflexions on hormone therapy of cancer of the breast].
    Namer M
    Bull Cancer; 1991; 78(11 Suppl):1-8. PubMed ID: 1845652
    [No Abstract]   [Full Text] [Related]  

  • 26. Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.
    Schmid M; Jakesz R; Samonigg H; Kubista E; Gnant M; Menzel C; Seifert M; Haider K; Taucher S; Mlineritsch B; Steindorfer P; Kwasny W; Stierer M; Tausch C; Fridrik M; Wette V; Steger G; Hausmaninger H
    J Clin Oncol; 2003 Mar; 21(6):984-90. PubMed ID: 12637461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of breast cancer.
    Cohen IA; Keller JH; Abate MA
    Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminoglutethimide in tamoxifen-resistant patients: The Melbourne Experience.
    Murray RM; Pitt P
    Cancer Res; 1982 Aug; 42(8 Suppl):3437s-3441s. PubMed ID: 6211229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adjuvant hormone therapy of primary breast cancer. Review of the literature].
    Focan C
    Rev Med Liege; 1991 May; 46(5):270-8. PubMed ID: 1830160
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of advanced breast cancer with aminoglutethimide--response after previous tamoxifen treatment.
    Bezwoda WR; Derman DP; Browde S; Goss G; Lange M
    S Afr Med J; 1984 Sep; 66(10):372-4. PubMed ID: 6484759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of hormone therapy with aminoglutethimide (Rodazol) in postmenopausal metastatic breast cancer].
    Schmidt UM; Brockmann B; Geschke E
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):276-9. PubMed ID: 1713564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study.
    Boccardo F; Rubagotti A; Amoroso D; Mesiti M; Romeo D; Caroti C; Farris A; Cruciani G; Villa E; Schieppati G; Mustacchi G;
    J Clin Oncol; 2001 Nov; 19(22):4209-15. PubMed ID: 11709564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The use of aminoglutethimide (orimeten) in disseminated breast cancer].
    Nadezhdina TM; Vyshinskaia GV; Lichinitser MR; Bassalyk LS; Garin AM
    Vopr Onkol; 1987; 33(5):79-82. PubMed ID: 3590672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aminoglutethimide therapy in advanced breast cancer].
    Kühböck J; Ludwig H; Pötzi P; Zielinski C
    Wien Med Wochenschr; 1985 Dec; 135(23-24):608-11. PubMed ID: 4096007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hormone therapy of patients with breast cancer].
    Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1984; 30(11):3-9. PubMed ID: 6393574
    [No Abstract]   [Full Text] [Related]  

  • 36. Systemic therapy of metastatic breast cancer: a review of the current trends.
    Legha SS; Blumenschein GR
    Oncology; 1982; 39(3):140-5. PubMed ID: 7078937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Endocrine therapy in breast carcinoma].
    Dogliotti L; Maschietto M; Ortega C
    Minerva Chir; 1988 Sep; 43(18 Suppl):63-6. PubMed ID: 3067123
    [No Abstract]   [Full Text] [Related]  

  • 38. Aminoglutethimide for metastatic breast cancer.
    Misbin RJ
    Ann Intern Med; 1977 Jun; 86(6):828-9. PubMed ID: 869369
    [No Abstract]   [Full Text] [Related]  

  • 39. Tamoxifen therapy of metastatic breast cancer.
    Manni A
    J Lab Clin Med; 1987 Mar; 109(3):290-9. PubMed ID: 2950193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage therapy in advanced breast cancer.
    Paridaens RJ
    Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1443-7. PubMed ID: 3830725
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.